Medroxyprogesterone Acetate for Granulosa Cell Tumors
Author Information
Author(s): S.T.A. Malik, M.L. Slevin
Primary Institution: ICRF Department of Medical Oncology, St. Bartholomew's and Homerton Hospitals, London, UK.
Hypothesis
Can medroxyprogesterone acetate (MPA) be an effective treatment for advanced granulosa cell tumors of the ovary?
Conclusion
MPA can induce tumor regression in advanced granulosa cell tumors that have become resistant to first-line chemotherapy.
Supporting Evidence
- Both patients showed clinical improvement after starting MPA.
- One patient had a significant decrease in the size of liver metastases.
- The second patient had a decrease in the size of a pelvic mass after increasing the MPA dose.
Takeaway
Two women with advanced ovarian tumors got better after taking a medicine called MPA, even after other treatments didn't work.
Methodology
Case studies of two patients treated with MPA after failing other treatments.
Limitations
The small number of cases limits the ability to generalize the findings.
Participant Demographics
One patient was 56 years old and nulliparous, and the other was 46 years old and multiparous.
Want to read the original?
Access the complete publication on the publisher's website